Rocket Lab’s Backlog and Neutron Rocket Could Drive Its Next Stock Move
Rocket Lab trades around $74 and has a 24/7 Wall St. price target of $119.32 with a buy rating. The company reported Q2 2026 revenue of $234 million, up 62% year over year, and a record $2.36 billion backlog. Its pending Iridium acquisition and the planned Q4 2026 debut of the Neutron rocket are key catalysts.
Rocket Lab's Q2 2026 revenue reached $234 million, 62% higher year over year and above consensus. GAAP EPS was -$0.08, affected by $8.58 million in acquisition costs. Backlog hit $2.36 billion. Shares recently traded near $74.31, with a 24/7 Wall St. target of $119.32 and buy rating at medium confidence.
The company has closed Mynaric and Motiv deals while Iridium remains pending. Neutron's planned Q4 2026 first flight is priced at $50–$55 million per launch. Other cited awards include $397 million Flatellite, $816 million SDA Tracking Layer Tranche 3, and a Golden Dome selection with Raytheon.
If Neutron flies and Iridium integration proceeds, Rocket Lab may influence how quickly satellite-based communications, imaging, and tracking services reach commercial and public users. Investors and aerospace workers could see gains or losses; government agencies and communities reliant on space data may benefit from more launch options, though delays or failures could slow those benefits.